CATALOGO DEI PRODOTTI DELLA RICERCA

LAWLOR, Rita Teresa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.775
NA - Nord America 3.624
AS - Asia 1.481
AF - Africa 13
SA - Sud America 10
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.915
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.604
GB - Regno Unito 1.215
CN - Cina 1.212
IT - Italia 835
IE - Irlanda 420
SE - Svezia 380
FR - Francia 341
DE - Germania 255
FI - Finlandia 131
VN - Vietnam 120
UA - Ucraina 55
HK - Hong Kong 47
BE - Belgio 29
KR - Corea 29
RU - Federazione Russa 24
AT - Austria 17
NL - Olanda 17
SG - Singapore 15
BF - Burkina Faso 12
CA - Canada 12
IR - Iran 10
TR - Turchia 10
IN - India 9
ES - Italia 8
AU - Australia 7
BG - Bulgaria 6
PL - Polonia 6
CL - Cile 5
GR - Grecia 5
JP - Giappone 5
CH - Svizzera 4
LU - Lussemburgo 4
LV - Lettonia 4
RO - Romania 4
AZ - Azerbaigian 3
BR - Brasile 3
JO - Giordania 3
KG - Kirghizistan 3
MK - Macedonia 3
PK - Pakistan 3
AL - Albania 2
BZ - Belize 2
CR - Costa Rica 2
CY - Cipro 2
CZ - Repubblica Ceca 2
EU - Europa 2
IL - Israele 2
LK - Sri Lanka 2
MX - Messico 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PE - Perù 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BY - Bielorussia 1
EE - Estonia 1
HR - Croazia 1
ID - Indonesia 1
IS - Islanda 1
MA - Marocco 1
PH - Filippine 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 8.915
Salva come PNG Salva come JPEG
Città #
Southend 1.153
Chandler 940
Verona 435
Dublin 387
Beijing 282
Jacksonville 242
Ann Arbor 212
Ashburn 189
Woodbridge 182
New York 167
Lawrence 133
Princeton 133
Wilmington 128
Jinan 122
Houston 96
Nanjing 90
Redmond 87
Shenyang 87
Dong Ket 81
Sindelfingen 66
Hebei 65
Helsinki 58
Zhengzhou 53
Seattle 45
Hong Kong 43
Haikou 39
Ningbo 36
Tianjin 35
Changsha 34
Taizhou 34
Jiaxing 32
Hangzhou 30
Brussels 29
Redwood City 28
Dearborn 27
Nanchang 27
Taiyuan 27
Washington 25
Seoul 24
Bologna 23
Guangzhou 23
Milan 22
Chicago 16
Chions 16
Lancaster 16
Vienna 16
Fairfield 15
Los Angeles 15
Norwalk 15
Singapore 15
Fuzhou 13
Bobo-Dioulasso 12
Falls Church 12
Lappeenranta 12
Pieve di Soligo 10
Lanzhou 9
San Francisco 9
Shanghai 9
Buffalo 8
Dongguan 8
Falkenstein 7
San Jose 7
Villafranca Di Verona 7
Padova 6
Rome 6
Trieste 6
Boardman 5
Bolzano 5
Clearwater 5
Düsseldorf 5
Illasi 5
Kemerovo 5
Palermo 5
Sofia 5
Sydney 5
Toronto 5
Amsterdam 4
Auburn Hills 4
Boydton 4
Bressanone 4
Cagliari 4
Casier 4
Edinburgh 4
Fremont 4
Kiel 4
Leawood 4
Luxembourg 4
Naples 4
Nova Milanese 4
Riga 4
Riva 4
San Diego 4
Tombolo 4
Zanjan 4
Amman 3
Augusta 3
Baku 3
Bishkek 3
Brescia 3
Cambridge 3
Totale 6.376
Salva come PNG Salva come JPEG
Nome #
Whole-genome landscape of pancreatic neuroendocrine tumours 155
DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples 149
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. 136
BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing 133
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 128
1177PUndiscovered immune heterogeneity in pancreatic adenocarcinoma (PDAC) 124
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 121
Genomic analyses identify molecular subtypes of pancreatic cancer 121
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 116
Reporting tumor molecular heterogeneity in histopathological diagnosis 116
RON is not a prognostic marker for resectable pancreatic cancer 114
Common Minimum Technical Standards and Protocols for Biobanks Dedicated to Cancer Research 114
Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients 104
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 103
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas 101
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 100
Genomic characterization of hepatoid tumors: context matters 100
Lost in translation: returning germline genetic results in genome-scale cancer research 99
Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors 99
PD-1, PD-L1 and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 98
International network of cancer genome projects 95
Research capacity. Enabling the genomic revolution in Africa 92
CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas 92
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 91
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 91
Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 90
Evaluation of cell-free DNA as a biomarker for pancreatic malignancies 89
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. 84
Urine Metabolic Signature of Pancreatic Ductal Adenocarcinoma by (1)H Nuclear Magnetic Resonance: Identification, Mapping, and Evolution 84
Ampulla of Vater carcinoma: Molecular landscape and clinical implications 84
Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo 83
A cross-species analysis in pancreatic neuroendocrine tumors reveals molecular subtypes with distinctive clinical, metastatic, developmental, and metabolic characteristics 82
428OImmune landscape of pancreatic neuroendocrine tumours (PanNETs) 82
Splice variants as novel targets in pancreatic ductal adenocarcinoma 81
Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages 81
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes 79
Biosampling and biobanking (Chapter7) 78
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 78
Loss of BAP1 Expression Occurs Frequently in Intrahepatic Cholangiocarcinoma 77
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer 77
A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk 77
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 76
Whole genomes redefine the mutational landscape of pancreatic cancer 74
Building capacity for sustainable research programmes for cancer in Africa 74
Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling 73
Hypermutation In Pancreatic Cancer 73
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 73
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 71
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 71
Gα15 in early onset of pancreatic ductal adenocarcinoma 71
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms 70
Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysis 70
Combined microRNA and mRNA microfluidic TaqMan array cards for the diagnosis of malignancy of multiple types of pancreatico-biliary tumors in fine-needle aspiration material 68
Epithelial-mesenchymal transition in undifferentiated carcinoma of the pancreas with and without osteoclast-like giant cells 68
New genomic landscapes and therapeutic targets for biliary tract cancers 66
Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations 65
Exosomal miRNA signatures of pancreatic lesions 65
Pancreatic cancer arising in the remnant pancreas is not always a relapse of the preceding primary 64
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 64
CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype 64
SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival 63
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 63
Comparative Lesions Analysis Through a Targeted Sequencing Approach 63
Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases 63
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases 63
Whole-exome sequencing of duodenal neuroendocrine tumors in patients with neurofibromatosis type 1 62
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 62
Biospecimens and Biobanking in Global Health 61
Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation 61
The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome 60
The Italian Rare Pancreatic Exocrine Cancer Initiative 60
The Global Genome Biodiversity Network (GGBN) Data Standard specification 58
Germline BRCA2 K3326X and CHEK2 I157T Mutations Increase Risk for Sporadic Pancreatic Ductal Adenocarcinoma 57
Reduced risk of pancreatic cancer associated with asthma and nasal allergies 56
European, Middle Eastern, and African Society for Biopreservation and Biobanking (ESBB). 2012 Conference Session on Biobanking in Emerging Countries 55
A Model of Collaboration ad Experiences between Bio-industry and Academic Biobanks 55
Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes 55
Combinatorial Effect of Magnetic Field and Radiotherapy in PDAC Organoids: A Pilot Study 55
Colorectal cancer with microsatellite instability: Right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival 55
Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis 54
Genome-wide association study identifies an early onset pancreatic cancer risk locus 53
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications 52
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice? 52
Bioengineered 3D models of human pancreatic cancer recapitulate in vivo tumour biology 52
Combinatorial Effect of Magnetic Field and Radiotherapy in Pancreatic Ductal Adenocarcinoma Organoids 52
Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case-control approaches 50
Multigene mutational profiling of biliary tract cancer is related to the pattern of recurrence in surgically resected patients 50
Biobanks in Low Resource Contexts 49
Endoscopic ultrasound guided fine needle biopsy samples to drive personalized medicine: A proof of concept study 49
Harnessing the epigenome to boost immunotherapy response in non-small cell lung cancer patients 49
IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation 49
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine 48
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions 48
Competitive Testing of the WHO 2010 versus the WHO 2017 Grading of Pancreatic Neuroendocrine Neoplasms: Data from a Large International Cohort Study 47
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 47
KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities 47
Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma 47
Histo-molecular oncogenesis of pancreatic cancer: From precancerous lesions to invasive ductal adenocarcinoma 46
A multimodality test to guide the management of patients with a pancreatic cyst 45
The mutant p53-driven secretome has oncogenic functions in pancreatic ductal adenocarcinoma cells 45
Totale 7.576
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.462
article - articoli 30.653
book - libri 223
conference - conferenze 539
curatela - curatele 0
other - altro 455
patent - brevetti 0
selected - selezionate 0
volume - volumi 592
Totale 64.924
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201974 0 0 0 0 0 0 0 0 0 0 50 24
2019/2020931 94 26 35 22 99 85 123 54 36 102 125 130
2020/20211.240 180 185 71 178 138 107 34 24 42 45 89 147
2021/20221.311 125 353 75 114 51 33 54 88 51 32 81 254
2022/20232.613 159 320 203 437 217 616 44 165 290 34 89 39
2023/20241.468 56 124 124 168 177 329 94 193 53 129 21 0
Totale 9.301